Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...

European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...

The lawsuit’s outcome could have major implications for millions of Americans, especially after Congress voted in 2025 to ...

The proposal would mark a significant change for the secretive PBM industry, which often shields crucial data from its clients.

As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.

First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...

California Gov. Gavin Newsom announced his office was filing a civil rights complaint with HHS accusing CMS Administrator Mehmet Oz of discrimination.

The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...

A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...

This week on "The Readout LOUD": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...